Provided by Tiger Trade Technology Pte. Ltd.

Trump Concept

3,249.51
+13.090.40%
Number of Gainers:19
Number of Losers:10
Number of Flat:2
PE:- -
High:3,262.57
Open:3,236.72
Low:3,231.31
Close:3,236.42
Volume:315.07M
Turnover:40.88B
Market Cap:6.16T
Float Cap:5.44T

Loading ...

MARA Holdings Amends Texas Data Center Project Agreement

TIPRANKS
·
Sep 26

Riot Platforms Repays Coinbase Credit Facility, Boosts Flexibility

TIPRANKS
·
Sep 26

Ralph Lauren Corp. Cl a Stock Underperforms Friday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Sep 26

Mara - Posts $100 Mln Security Deposit with Electric Utility Company for Site Power Capacity - SEC Filing

THOMSON REUTERS
·
Sep 26

Wall Street Closes Higher as All Three Major Indexes Gain and Post Weekly Advances, Shrugging Off Bond Selloff; Apple Sets Another Record

Deep News
·
Sep 26

Public Storage Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 26

CleanSpark, Inc. Announces Closing of $2.276 Billion of Senior Secured Notes

THOMSON REUTERS
·
Sep 26

General Motors Co. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 26

PNC Financial Services Group Inc. Stock Underperforms Friday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Sep 26

Global Markets-Battered Bonds Draw Support from Falling Oil Prices

Reuters
·
Sep 26

Merck, Daiichi Sankyo Withdraw US Application for Lung Cancer Drug

Reuters
·
Sep 26

Merck, Daiichi Sankyo voluntarily withdraw BLA for ifinatamab deruxtecan

TIPRANKS
·
Sep 26

Microsoft Corp. Stock Advances 3.7%, Outperforms Peers

Dow Jones
·
Sep 26

Merck & Co - Daiichi Sankyo and Merck Withdraw Bla for Ifinatamab Deruxtecan in Es-Sclc in U.S.

THOMSON REUTERS
·
Sep 26

Merck & Co - Withdrawal Based on FDA Discussions; Phase 2 Data Do not Satisfy Approval Requirements

THOMSON REUTERS
·
Sep 26

Merck & Co - Patient Enrollment Continues in Ideate-Lung02 Phase 3 Trial for Ifinatamab Deruxtecan

THOMSON REUTERS
·
Sep 26

Merck & Co - Two Additional Phase 3 Trials Underway for Ifinatamab Deruxtecan in Crpc and Escc

THOMSON REUTERS
·
Sep 26

BioAge Labs to Present at Upcoming Investor Conferences

GlobeNewswire
·
Sep 26

Oracle Corp Says Director and Chief Executive Officer Clayton M. Magouyrk's 2026 Total Compensation was $627.5 Mln- SEC Filing

THOMSON REUTERS
·
Sep 26

Cboe data shows mixed options sentiment in Mara Holdings with shares down 2.86%

TIPRANKS
·
Sep 26